A detailed history of Dimensional Fund Advisors LP transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 21,015 shares of BGNE stock, worth $3.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,015
Previous 11,499 82.76%
Holding current value
$3.73 Million
Previous $1.64 Million 187.68%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$143.93 - $224.51 $1.37 Million - $2.14 Million
9,516 Added 82.76%
21,015 $4.72 Million
Q2 2024

Aug 09, 2024

BUY
$129.52 - $174.32 $808,981 - $1.09 Million
6,246 Added 118.9%
11,499 $1.64 Million
Q1 2024

May 10, 2024

SELL
$141.8 - $181.47 $855,904 - $1.1 Million
-6,036 Reduced 53.47%
5,253 $821,000
Q4 2023

Feb 07, 2024

SELL
$158.67 - $201.58 $30,940 - $39,308
-195 Reduced 1.7%
11,289 $2.04 Million
Q3 2023

Nov 09, 2023

SELL
$179.87 - $225.13 $127,707 - $159,842
-710 Reduced 5.82%
11,484 $2.07 Million
Q2 2023

Aug 09, 2023

SELL
$178.3 - $266.78 $49,032 - $73,364
-275 Reduced 2.21%
12,194 $2.17 Million
Q1 2023

May 12, 2023

SELL
$215.53 - $274.5 $104,316 - $132,858
-484 Reduced 3.74%
12,469 $2.69 Million
Q4 2022

Feb 09, 2023

SELL
$125.51 - $229.3 $170,944 - $312,306
-1,362 Reduced 9.51%
12,953 $2.85 Million
Q3 2022

Nov 10, 2022

SELL
$131.8 - $202.24 $122,310 - $187,678
-928 Reduced 6.09%
14,315 $1.93 Million
Q2 2022

Aug 12, 2022

SELL
$121.11 - $216.05 $15,138 - $27,006
-125 Reduced 0.81%
15,243 $2.46 Million
Q1 2022

May 13, 2022

BUY
$146.52 - $269.56 $299,926 - $551,789
2,047 Added 15.37%
15,368 $2.94 Million
Q4 2021

Feb 09, 2022

SELL
$248.56 - $389.34 $50,209 - $78,646
-202 Reduced 1.49%
13,321 $3.61 Million
Q3 2021

Nov 12, 2021

SELL
$249.6 - $403.14 $1.73 Million - $2.79 Million
-6,919 Reduced 33.85%
13,523 $4.91 Million
Q2 2021

Aug 12, 2021

SELL
$292.75 - $367.01 $938,849 - $1.18 Million
-3,207 Reduced 13.56%
20,442 $7.06 Million
Q1 2021

May 14, 2021

BUY
$260.64 - $382.12 $107,383 - $157,433
412 Added 1.77%
23,649 $8.16 Million
Q4 2020

Feb 25, 2021

BUY
$221.31 - $316.61 $5.14 Million - $7.36 Million
23,237 New
23,237 $5.99 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.4B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.